Detalhe da pesquisa
1.
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review.
Headache
; 62(4): 453-472, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35363381
2.
Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.
Headache
; 60(3): 576-588, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943195
3.
The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community.
Alzheimers Dement
; 15(6): 828-839, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076376
4.
Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.
J Headache Pain
; 20(1): 84, 2019 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340760
5.
Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.
J Headache Pain
; 20(1): 22, 2019 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30823868
6.
Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study.
BMC Psychiatry
; 13: 193, 2013 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23866017
7.
Prevalence Rates of Primary Headache Disorders and Evaluation and Treatment Patterns Among Korean Neurologists.
J Clin Neurol
; 18(5): 571-580, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36062775
8.
Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models.
J Clin Psychopharmacol
; 31(2): 226-30, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21346606
9.
Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a German observational study.
BMC Psychiatry
; 11: 173, 2011 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22044502
10.
Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine.
BMC Psychiatry
; 11: 150, 2011 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21933428
11.
Safety and efficacy of galcanezumab in Taiwanese patients: a post-hoc analysis of phase 3 studies in episodic and chronic migraine.
Curr Med Res Opin
; 36(10): 1653-1666, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32845740
12.
Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years.
Schizophr Res
; 107(2-3): 165-72, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18842393
13.
Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients.
Schizophr Res
; 100(1-3): 342-8, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18255271
14.
Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
Clin Neurophysiol
; 118(7): 1532-7, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17531532
15.
Dopaminergic modulation of semantic priming in healthy volunteers.
Biol Psychiatry
; 60(6): 604-11, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16603132
16.
Differential dopaminergic modulation of executive control in healthy subjects.
Psychopharmacology (Berl)
; 178(4): 420-30, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15765257
17.
High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.
Parkinsonism Relat Disord
; 11(6): 393-8, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15993640
18.
High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study.
Arch Gerontol Geriatr
; 41(3): 239-53, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16029905
19.
Pergolide restores sleep maintenance but impairs sleep EEG synchronization in patients with restless legs syndrome.
Sleep Med
; 3(1): 49-54, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14592254
20.
Approvals and indications of CGRP antibodies.
Lancet Neurol
; 18(8): 718, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31301747